MacroGenics | MGNX - Ordinary Share Capital

Stock Price
3.19
Daily Change
0.01 0.31%
Monthly
0.63%
Yearly
86.55%
Q2 Forecast
3.12

MacroGenics reported $63.32M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
AbbVie USD 1.77B 1.75B Jun/2025
Amgen USD 539M 1000K Dec/2025
AstraZeneca USD 1.55B 206K Dec/2025
Biogen USD 146.7M 200K Sep/2025
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
Daiichi Sankyo JPY 1.85B 9K Dec/2025
Eli Lilly USD 946.83M 354.23M Jun/2025
Genmab DKK 61.62M 52K Dec/2025
Geron USD 638.36M 338K Dec/2025
Gilead Sciences USD 1.24B 1000K Dec/2025
J&J USD 2.41B 1.74M Dec/2025
Karyopharm Therapeutics USD 18.31M 18.3M Dec/2025
MacroGenics USD 63.32M 60K Dec/2025
Merck USD 2.49B 15.79M Sep/2025
Pfizer USD 5.69B 1000K Sep/2025
Puma Biotechnology USD 5K 0 Jun/2024
Regeneron Pharmaceuticals USD 105.3M 1.1M Sep/2025
Roche Holding CHF 795.62M 699.54K Dec/2025
Xencor USD 71.87M 529K Dec/2025